AKEBIA THERAPEUTICS, INC. Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property
AKEBIA THERAPEUTICS, INC. (AKBA) reported Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets · last filed 2022-03-01
- AKEBIA THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for the quarter ending 2016-12-31 was $0.00.
- AKEBIA THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2021 was $0.00.
- AKEBIA THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2020 was $0.00.
- AKEBIA THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2019 was -$2.05M.
- AKEBIA THERAPEUTICS, INC. gain (loss) on disposition of property plant equipment, excluding oil and gas property and timber property for fiscal 2018 was $0.00.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 3 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 9 month | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-01 | ||
| 2020-12-31 | $0.00 10-K · filed 2022-03-01 | ||
| 2019-12-31 | -$2.05M 10-K · filed 2022-03-01 | ||
| 2018-12-31 | $0.00 10-K · filed 2021-02-25 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$306.00K 10-K · filed 2019-03-26 | |
| 2016-09-30 | -$306.00K 10-Q · filed 2017-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |